药明生物(02269)发布公告,宣布其香港主要营业地点的地址将于2025年4月1日起更改至香港夏悫道16号远东金融中心17楼。同时,公司还披露了与爱尔兰疫苗设施相关的资产交易的完成情况。
根据公告,资产交易的对价总额为5亿美元,其中包括买方在交割时支付的4.07亿美元,买方在交割时向托管账户存入的3000万美元,以及剩余的6263万美元将通过卖方先前从买方收取的经摊销预付款抵销。该交易已于2025年3月31日完成交割,标志着公司在疫苗设施方面的重要进展。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.